Bone BiologicsBBLG
13F holders, Q3 2025 (September 30)7holders +3
3new positions
0sold out
$2.79avg. 13F price*
At the end of Q3 2025, 7 institutions reported holding Bone Biologics Corp. (BBLG) in their 13F filings, up 3 from Q2 2025. 3 opened new positions and 0 sold out. The largest holders were DRW Securities, LLC ($31K), Tower Research Capital LLC (TRC) ($4K) and SBI Securities Co., Ltd. ($642).
- Company
- Bone Biologics Corp.
- CUSIP
- 098070600
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $32K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 12,737 shares bought and 47 shares sold, net +12,690 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| DRW Securities, LLC | 0.00% | New | 11,027 | $31K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +632.0% | 1,464 | $4K |
| SBI Securities Co., Ltd. | 0.00% | New | 230 | $642 |
| Citigroup Inc. | 0.00% | New | 206 | $575 |
| Clear Street Group Inc. | 0.00% | — | 138 | $385 |
| UBS Group AG | 0.00% | Reduce -41.6% | 66 | $184 |
| Bank of America Corp. | 0.00% | Add +250.0% | 14 | $39 |
"% of holder's portfolio" is BBLG's weight in each manager's 13F, not the share of Bone Biologics Corp. the manager owns.